Silo Pharma Q3 2026 Results: Net Loss of $359K, Loss Narrows
For the nine months ended September 30, 2026, Silo Pharma reported a net loss of $2.84 million, an improvement from the $3.35 million loss in the prior year period. The company's cash position increased to $6.09 million, bolstered by a $0.70 million gain from the termination of a sublicense agreement and financing activities.
- Key figure
- Net loss $359K